162 related articles for article (PubMed ID: 21709377)
1. Cost-effectiveness of a health intervention program with risk reductions for getting demented: results of a Markov model in a Swedish/Finnish setting.
Zhang Y; Kivipelto M; Solomon A; Wimo A
J Alzheimers Dis; 2011; 26(4):735-44. PubMed ID: 21709377
[TBL] [Abstract][Full Text] [Related]
2. Results of a Markov model analysis to assess the cost-effectiveness of statin therapy for the primary prevention of cardiovascular disease in Korea: the Korean Individual-Microsimulation Model for Cardiovascular Health Interventions.
Kang HY; Ko SK; Liew D
Clin Ther; 2009 Dec; 31(12):2919-30; discussion 2916-8. PubMed ID: 20110032
[TBL] [Abstract][Full Text] [Related]
3. Costs and consequences of clopidogrel versus aspirin for secondary prevention of ischaemic events in (high-risk) atherosclerotic patients in Sweden: a lifetime model based on the CAPRIE trial and high-risk CAPRIE subpopulations.
Logman JF; Heeg BM; Herlitz J; van Hout BA
Appl Health Econ Health Policy; 2010; 8(4):251-65. PubMed ID: 20578780
[TBL] [Abstract][Full Text] [Related]
4. Early assessment of the likely cost-effectiveness of a new technology: A Markov model with probabilistic sensitivity analysis of computer-assisted total knee replacement.
Dong H; Buxton M
Int J Technol Assess Health Care; 2006; 22(2):191-202. PubMed ID: 16571195
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of memantine for moderate to severe Alzheimer's disease in Sweden.
Jönsson L
Am J Geriatr Pharmacother; 2005 Jun; 3(2):77-86. PubMed ID: 16129384
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of extended adjuvant letrozole therapy after 5 years of adjuvant tamoxifen therapy in postmenopausal women with early-stage breast cancer.
Delea TE; Karnon J; Smith RE; Johnston SR; Brandman J; Sung JC; Gross PE
Am J Manag Care; 2006 Jul; 12(7):374-86. PubMed ID: 16834524
[TBL] [Abstract][Full Text] [Related]
7. The cost effectiveness and cost utility of valsartan in chronic heart failure therapy in Italy: a probabilistic markov model.
Pradelli L; Iannazzo S; Zaniolo O
Am J Cardiovasc Drugs; 2009; 9(6):383-92. PubMed ID: 19929036
[TBL] [Abstract][Full Text] [Related]
8. The cost-effectiveness of Maze procedures using ablation techniques at the time of mitral valve surgery.
Quenneville SP; Xie X; Brophy JM
Int J Technol Assess Health Care; 2009 Oct; 25(4):485-96. PubMed ID: 19818194
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting.
Manser R; Dalton A; Carter R; Byrnes G; Elwood M; Campbell DA
Lung Cancer; 2005 May; 48(2):171-85. PubMed ID: 15829317
[TBL] [Abstract][Full Text] [Related]
10. Cost effectiveness of the determination of autoantibodies against cyclic citrullinated peptide in the early diagnosis of rheumatoid arthritis.
Konnopka A; Conrad K; Baerwald C; König HH
Ann Rheum Dis; 2008 Oct; 67(10):1399-405. PubMed ID: 18192304
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of salmeterol, fluticasone, and combination therapy for COPD.
Oba Y
Am J Manag Care; 2009 Apr; 15(4):226-32. PubMed ID: 19355795
[TBL] [Abstract][Full Text] [Related]
12. The costs and benefits of enhanced depression care to employers.
Wang PS; Patrick A; Avorn J; Azocar F; Ludman E; McCulloch J; Simon G; Kessler R
Arch Gen Psychiatry; 2006 Dec; 63(12):1345-53. PubMed ID: 17146009
[TBL] [Abstract][Full Text] [Related]
13. Community or patient preferences for cost-effectiveness of cardiac rehabilitation: does it matter?
Oldridge N; Furlong W; Perkins A; Feeny D; Torrance GW
Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):608-15. PubMed ID: 18800005
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of prostate cancer chemoprevention: a quality of life-years analysis.
Svatek RS; Lee JJ; Roehrborn CG; Lippman SM; Lotan Y
Cancer; 2008 Mar; 112(5):1058-65. PubMed ID: 18186497
[TBL] [Abstract][Full Text] [Related]
15. Cost effectiveness of community-based physical activity interventions.
Roux L; Pratt M; Tengs TO; Yore MM; Yanagawa TL; Van Den Bos J; Rutt C; Brownson RC; Powell KE; Heath G; Kohl HW; Teutsch S; Cawley J; Lee IM; West L; Buchner DM
Am J Prev Med; 2008 Dec; 35(6):578-88. PubMed ID: 19000846
[TBL] [Abstract][Full Text] [Related]
16. A cost-effectiveness analysis of subcutaneous interferon beta-1a 44mcg 3-times a week vs no treatment for patients with clinically isolated syndrome in Sweden.
Fredrikson S; McLeod E; Henry N; Pitcher A; Lowin J; Cuche M; Fajutrao L; Perard R; Bates D; Chan A
J Med Econ; 2013; 16(6):756-62. PubMed ID: 23556422
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of multi-component interventions to prevent delirium in older people admitted to medical wards.
Akunne A; Murthy L; Young J
Age Ageing; 2012 May; 41(3):285-91. PubMed ID: 22282171
[TBL] [Abstract][Full Text] [Related]
18. Net costs of dementia in Sweden - an incidence based 10 year simulation study.
Sköldunger A; Wimo A; Johnell K
Int J Geriatr Psychiatry; 2012 Nov; 27(11):1112-7. PubMed ID: 22298311
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the cost-effectiveness of a high- and a low-intensity smoking cessation intervention in Sweden: a randomized trial.
Nohlert E; Helgason AR; Tillgren P; Tegelberg A; Johansson P
Nicotine Tob Res; 2013 Sep; 15(9):1519-27. PubMed ID: 23404735
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of supervised exercise therapy in heart failure patients.
Kühr EM; Ribeiro RA; Rohde LE; Polanczyk CA
Value Health; 2011; 14(5 Suppl 1):S100-7. PubMed ID: 21839879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
